Aclarion, Inc. (ACONW) stock

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30

$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Aclarion EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Aclarion has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACONW.

Revenue growth33.1% · median -21.8%

Gross margin21.8% · median -29.0%

Operating margin-11592.1% · median -28628.9%

Net margin-10978.5% · median -25282.6%

Advertisement
300 × 250